NL7909199A - Farmaceutisch preparaat voor het behandelen van nieuw- vormingsziekten en werkwijzen voor het bereiden ervan. - Google Patents
Farmaceutisch preparaat voor het behandelen van nieuw- vormingsziekten en werkwijzen voor het bereiden ervan. Download PDFInfo
- Publication number
- NL7909199A NL7909199A NL7909199A NL7909199A NL7909199A NL 7909199 A NL7909199 A NL 7909199A NL 7909199 A NL7909199 A NL 7909199A NL 7909199 A NL7909199 A NL 7909199A NL 7909199 A NL7909199 A NL 7909199A
- Authority
- NL
- Netherlands
- Prior art keywords
- thiazolidine
- carboxylic acid
- pharmaceutically acceptable
- acceptable salt
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97172978 | 1978-12-21 | ||
US05/971,729 US4384001A (en) | 1978-12-21 | 1978-12-21 | Treatment of tumors with thiazolidine-4-carboxylic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
NL7909199A true NL7909199A (nl) | 1980-06-24 |
Family
ID=25518727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL7909199A NL7909199A (nl) | 1978-12-21 | 1979-12-20 | Farmaceutisch preparaat voor het behandelen van nieuw- vormingsziekten en werkwijzen voor het bereiden ervan. |
Country Status (16)
Country | Link |
---|---|
US (1) | US4384001A (es) |
JP (1) | JPS55115822A (es) |
AU (1) | AU5390579A (es) |
BE (1) | BE880744A (es) |
CA (1) | CA1149284A (es) |
DE (1) | DE2951050A1 (es) |
DK (1) | DK542979A (es) |
ES (1) | ES8102108A1 (es) |
FR (1) | FR2444459A1 (es) |
GB (1) | GB2039736B (es) |
IL (1) | IL58948A0 (es) |
IT (1) | IT1193348B (es) |
LU (1) | LU82013A1 (es) |
NL (1) | NL7909199A (es) |
SE (1) | SE7910300L (es) |
ZA (1) | ZA796918B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE53332B1 (en) * | 1980-03-14 | 1988-10-26 | Efamol Ltd | Pharmaceutical compositions |
JPS57128625A (en) * | 1981-01-30 | 1982-08-10 | Rikagaku Kenkyusho | Carcinostatic |
US4335210A (en) * | 1981-02-11 | 1982-06-15 | Cornell Research Foundation | Method of producing L-cysteine |
FR2547729B1 (fr) * | 1983-06-24 | 1986-05-02 | Riker Laboratories Inc | Medicament a base d'acide dl thiazolidine carboxylique |
FR2547728B1 (fr) * | 1983-06-24 | 1986-05-02 | Riker Laboratories Inc | Medicament a base d'acide d thiazolidine carboxylique |
JPS62501769A (ja) * | 1984-12-18 | 1987-07-16 | デイビツト ラビン | 細胞毒性アルデヒドとベニシラミンとの反応性成物を含有する抗腫瘍組成物及びその使用方法 |
JPH066578B2 (ja) * | 1985-12-27 | 1994-01-26 | 三共株式会社 | チアゾリジン誘導体 |
JPH01170063U (es) * | 1988-05-11 | 1989-11-30 | ||
JPH0467539U (es) * | 1990-10-18 | 1992-06-16 | ||
EP0494405B2 (en) * | 1991-01-10 | 2000-04-19 | Transcend Therapeutics, Inc. | Use of L-2-oxo thiazolidine-4-carboxylate for the treatment of pulmonary diseases |
ES2277787B1 (es) * | 2006-01-02 | 2008-06-16 | Universidad De Cadiz | Empleo de tioprolina en tratamientos de reduccion de peso corporal. |
-
1978
- 1978-12-21 US US05/971,729 patent/US4384001A/en not_active Expired - Lifetime
-
1979
- 1979-12-12 GB GB7942753A patent/GB2039736B/en not_active Expired
- 1979-12-13 IL IL58948A patent/IL58948A0/xx unknown
- 1979-12-14 SE SE7910300A patent/SE7910300L/xx unknown
- 1979-12-17 AU AU53905/79A patent/AU5390579A/en not_active Abandoned
- 1979-12-18 IT IT28170/79A patent/IT1193348B/it active
- 1979-12-19 ES ES487052A patent/ES8102108A1/es not_active Expired
- 1979-12-19 BE BE0/198657A patent/BE880744A/fr not_active IP Right Cessation
- 1979-12-19 DE DE19792951050 patent/DE2951050A1/de not_active Withdrawn
- 1979-12-19 CA CA000342263A patent/CA1149284A/en not_active Expired
- 1979-12-19 DK DK542979A patent/DK542979A/da unknown
- 1979-12-19 LU LU82013A patent/LU82013A1/fr unknown
- 1979-12-19 FR FR7931158A patent/FR2444459A1/fr active Granted
- 1979-12-20 ZA ZA00796918A patent/ZA796918B/xx unknown
- 1979-12-20 JP JP16495079A patent/JPS55115822A/ja active Granted
- 1979-12-20 NL NL7909199A patent/NL7909199A/nl not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ES487052A0 (es) | 1980-12-16 |
FR2444459A1 (fr) | 1980-07-18 |
US4384001A (en) | 1983-05-17 |
BE880744A (fr) | 1980-06-19 |
CA1149284A (en) | 1983-07-05 |
ZA796918B (en) | 1980-11-26 |
SE7910300L (sv) | 1980-06-22 |
ES8102108A1 (es) | 1980-12-16 |
IL58948A0 (en) | 1980-03-31 |
GB2039736A (en) | 1980-08-20 |
JPS55115822A (en) | 1980-09-06 |
DK542979A (da) | 1980-06-22 |
IT7928170A0 (it) | 1979-12-18 |
LU82013A1 (fr) | 1981-02-03 |
JPS6328045B2 (es) | 1988-06-07 |
IT1193348B (it) | 1988-06-15 |
AU5390579A (en) | 1980-06-26 |
GB2039736B (en) | 1983-04-13 |
FR2444459B1 (es) | 1983-04-01 |
DE2951050A1 (de) | 1980-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK137996A3 (en) | Cancer treatment and metastasis prevention | |
NL7909199A (nl) | Farmaceutisch preparaat voor het behandelen van nieuw- vormingsziekten en werkwijzen voor het bereiden ervan. | |
US6407125B1 (en) | Pharmacological agent and method of treatment | |
US20060074063A1 (en) | Pharmacological agent and method of treatment | |
CN111346081B (zh) | 包含正戊酸、吲哚丙酸和正丁酸钠的药物组合物的新用途 | |
WO2002020486A2 (en) | Picolinic acid derivatives for the prevention and treatment of cancer in animals | |
CN115463118A (zh) | 和厚朴酚在制备治疗或预防毛细血管瘤的药物中的用途 | |
JP2003522786A (ja) | 薬理学的薬剤、及び治療の方法 | |
AU709620B2 (en) | New applications of lysozyme dimer | |
DE60032915T2 (de) | Gallium komplexe von 3-hydroxy-4-pyronen zur behandlung von durch intrazelluläre prokaryoten, dns- und retro-viren verursachten infektionen | |
KR20060061367A (ko) | 디파이브로타이드를 단독으로 또는 다른 항암제들과조합하여 포함하는 항암제제 | |
Taliaferro | The Role of the Spleen and the Lymphoid-macrophage System in the Quinine Treatment of Gallinaceum Malaria: I. Acquired Immunity and Phagocytosis | |
JPS6379824A (ja) | 制癌剤 | |
WO2021023291A1 (zh) | 原黄素在肺癌治疗中的应用 | |
US6441009B1 (en) | Agent and method of preventing and treating heavy metal exposure and toxicity | |
KR20060038387A (ko) | 화학요법을 받고 있는 암 환자를 치료하는 방법 | |
Boughattas et al. | Modulation of cisplatin chronotoxicity related to reduced glutathione in mice | |
CN111514290A (zh) | 一种葫芦素组合物及其用途 | |
RU2680804C1 (ru) | Стабильное средство лечения болезней суставов | |
CN113456643B (zh) | 一种含普那布林的药物组合及其应用 | |
NL8501840A (nl) | Inhibitie van tumorontwikkeling. | |
RU2426531C1 (ru) | Жидкая водная фармацевтическая композиция амброксола и фармацевтический препарат на ее основе, предназначенные для лечения заболеваний дыхательных путей с образованием вязкой мокроты (варианты) | |
RU2282437C1 (ru) | Средство для лечения болезней суставов | |
RU2681546C1 (ru) | Способ экстренной профилактики клещевого вирусного энцефалита | |
US20060240117A1 (en) | Snake powder extract for treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A85 | Still pending on 85-01-01 | ||
BV | The patent application has lapsed |